Marisa Hill

Efficacy findings from a randomized phase III trial of capecitabine plus oxaliplatin versus bolus 5-FU/LV for stage III colon cancer (NO16968): Impact of age on disease-free survival (DFS).

Daniel G. Haller, Jim Cassidy, Josep Tabernero et al. · Journal of Clinical Oncology · 2010 · 49 citations

Oxaliplatin Versus, Cancer Management, Pathology +18

Evaluation of Circulating Tumor DNA for Methylated <i>BCAT1</i> and <i>IKZF1</i> to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC)

Benjamin Musher, Joshua Melson, Gianni Amato et al. · Cancer Epidemiology Biomarkers & Prevention · 2020 · 32 citations · Full text

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Jeff P. Sharman, Talha Munir, Sebastian Grosicki et al. · Journal of Clinical Oncology · 2025 · 20 citations · Full text

BRUIN CLL-321: Randomized Phase III Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab (IdelaR) or Bendamustine Plus Rituximab (BR) in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jeff P. Sharman, Talha Munir, Sebastian Grosicki et al. · Blood · 2024 · 17 citations · Full text

The effect of methionine on the progression of hepatocellular carcinoma induced by ethionine.

Z Brada, Altman Nh, Marisa Hill et al. · PubMed · 1982 · 12 citations

Hepatology, Medicine, Liver Physiology +15